GSK said Chief Executive Emma Walmsley would step down and be succeeded by commercial chief Luke Miels, as the drugmaker works to replenish its product lineup. Walmsley will step down at the end of ...

(Reuters) -GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on Monday, a surprise switch as the British firm looks to rev up its ...

Emma Walmsley, the CEO who led the U.K. drugmaker GSK through the Covid-19 pandemic and the transformative spinoff of its consumer-health brands, will step down at the end of the year, the company ...

GSK CEO Emma Walmsley will be stepping aside after nine years. Shares of GSK rallied on Monday after the U.K. pharmaceutical giant turned to an insider to become its next CEO. Luke Miels, chief ...

Dame Emma Walmsley, CEO of GSK arrives for a business roundtable attended by President Donald Trump and Britain's Prime Minister Keir Starmer at Chequers near ...

GSK chief executive Emma Walmsley will be replaced by chief commercial officer Luke Miels on January 1 – Copyright GETTY IMAGES NORTH AMERICA/AFP Kayla Bartkowski ...

GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.  | GSK is ...

Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...

Shares of GSK rallied on Monday after the U.K. pharmaceutical giant turned to an insider to become its next CEO. Luke Miels, chief commercial officer, will take the reigns on Jan. 1 from Emma Walmsley ...